MNKD: MannKind Corp.
About
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Current Value
$6.881 Year Return
Current Value
$6.881 Year Return
Key Details
Market Cap
$1.89B
P/E Ratio
97.58
1Y Stock Return
84.91%
1Y Revenue Growth
51.35%
Dividend Yield
0.00%
Price to Book
-9.0
Strategies that include MNKD
Stock's related to MNKD
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| PGEN | 46.56% | $228.91M | -28.00% | 0.00% |
| MTZ | 45.14% | $11.28B | +151.46% | 0.00% |
| NTLA | 43.39% | $1.44B | -50.35% | 0.00% |
| BEAM | 42.62% | $2.09B | -9.52% | 0.00% |
| PRTA | 40.49% | $756.01M | -56.52% | 0.00% |
| CPRX | 40.15% | $2.55B | +55.68% | 0.00% |
| OPEN | 39.23% | $1.14B | -31.62% | 0.00% |
| AKRO | 38.66% | $2.17B | +93.09% | 0.00% |
| ALLO | 38.43% | $444.50M | -24.82% | 0.00% |
| ARWR | 38.18% | $2.31B | -34.44% | 0.00% |
| VBTX | 37.80% | $1.58B | +53.68% | 2.75% |
| STHO | 37.72% | $150.51M | -5.99% | 0.00% |
| ACEL | 37.68% | $940.36M | +12.85% | 0.00% |
| TCBK | 37.56% | $1.55B | +31.56% | 2.74% |
| HEES | 37.55% | $2.05B | +23.47% | 1.96% |
| PDSB | 37.54% | $78.37M | -66.59% | 0.00% |
| LOB | 37.52% | $2.08B | +41.52% | 0.26% |
| SCL | 37.47% | $1.69B | -6.79% | 2.01% |
| RGNX | 37.35% | $473.65M | -51.96% | 0.00% |
| CHCO | 37.30% | $1.89B | +32.97% | 2.29% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SRRK | 0.02% | $2.61B | +134.91% | 0.00% |
| KRRO | 0.03% | $436.84M | +20.68% | 0.00% |
| CRTO | -0.10% | $2.10B | +58.23% | 0.00% |
| JNPR | -0.11% | $11.61B | +30.55% | 2.49% |
| AVAL | -0.18% | $791.37M | -4.11% | 7.14% |
| FCN | 0.18% | $7.10B | -10.74% | 0.00% |
| UUU | 0.26% | $4.97M | -41.89% | 0.00% |
| XEL | 0.35% | $41.42B | +15.91% | 3.12% |
| ADBE | 0.37% | $219.93B | -18.23% | 0.00% |
| APRE | 0.38% | $16.41M | -19.47% | 0.00% |
| CARV | 0.38% | $8.48M | -8.79% | 0.00% |
| LPLA | 0.44% | $23.55B | +38.13% | 0.38% |
| OCFT | -0.45% | $80.95M | -30.38% | 0.00% |
| EDSA | 0.48% | $7.11M | -21.79% | 0.00% |
| ALAR | 0.48% | $89.09M | +158.08% | 0.00% |
| WM | -0.62% | $87.92B | +27.58% | 1.34% |
| HIHO | -0.62% | $8.63M | 0.00% | 6.12% |
| CLMT | 0.68% | $1.79B | +35.14% | 0.00% |
| AIZ | -0.74% | $11.24B | +33.00% | 1.31% |
| MX | 0.74% | $135.79M | -45.52% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -11.34% | $21.46B | +15.84% | 1.11% |
| TEM | -11.07% | $8.50B | 0.00% | 0.00% |
| TCTM | -10.24% | $8.10M | -42.99% | 0.00% |
| AIFU | -9.88% | $67.49M | -83.02% | 0.00% |
| CLLS | -8.67% | $141.30M | -30.99% | 0.00% |
| PHI | -8.58% | $4.83B | -1.80% | 7.58% |
| PRPO | -8.00% | $9.10M | -13.65% | 0.00% |
| HUSA | -7.80% | $16.69M | -11.56% | 0.00% |
| CCEC | -6.48% | $1.02B | +28.03% | 3.26% |
| MCK | -6.17% | $78.15B | +35.51% | 0.42% |
| SBUX | -6.11% | $111.45B | -5.15% | 2.37% |
| CME | -6.08% | $82.76B | +9.21% | 1.98% |
| PULM | -5.97% | $19.83M | +202.98% | 0.00% |
| LQDA | -5.70% | $859.91M | +53.94% | 0.00% |
| GAN | -5.22% | $83.39M | +21.19% | 0.00% |
| WPRT | -4.82% | $76.83M | -36.88% | 0.00% |
| OXBR | -4.69% | $19.05M | +178.18% | 0.00% |
| BTCT | -4.07% | $42.61M | +353.33% | 0.00% |
| NGL | -3.96% | $572.94M | +5.60% | 0.00% |
| WHLM | -3.82% | $17.64M | -29.34% | 0.00% |
ETF's related to MNKD
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| PBE | 57.14% | $258.53M | 0.58% |
| XBI | 55.32% | $6.58B | 0.35% |
| FBT | 53.83% | $1.11B | 0.56% |
| GNOM | 52.79% | $70.59M | 0.5% |
| IBB | 52.76% | $6.66B | 0.45% |
| IWC | 48.67% | $933.99M | 0.6% |
| PTH | 48.46% | $143.31M | 0.6% |
| NUSC | 48.13% | $1.27B | 0.31% |
| ESML | 48.01% | $1.90B | 0.17% |
| VTWO | 47.76% | $12.38B | 0.1% |
| IWO | 47.71% | $12.56B | 0.24% |
| IWM | 47.49% | $75.73B | 0.19% |
| SMMD | 47.48% | $1.24B | 0.15% |
| BBH | 47.45% | $397.87M | 0.35% |
| VIOO | 46.96% | $3.12B | 0.1% |
| IJS | 46.95% | $7.37B | 0.18% |
| VB | 46.85% | $63.63B | 0.05% |
| VBK | 46.75% | $19.31B | 0.07% |
| XAR | 46.67% | $2.56B | 0.35% |
| SFYX | 46.63% | $105.21M | 0.06% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| COMT | -0.06% | $829.06M | 0.48% |
| GSG | 0.07% | $914.42M | 0.75% |
| BSCO | 0.16% | $2.35B | 0.1% |
| CORN | -0.35% | $61.12M | 0.2% |
| XBIL | 0.53% | $637.70M | 0.15% |
| KRBN | 0.86% | $242.47M | 0.85% |
| CCOR | -0.97% | $109.04M | 1.18% |
| TBIL | -1.00% | $4.38B | 0.15% |
| DBE | -1.18% | $50.13M | 0.77% |
| FLRN | -1.35% | $2.33B | 0.15% |
| CANE | 1.53% | $17.72M | 0.29% |
| FMF | 1.55% | $244.61M | 0.95% |
| PREF | -1.55% | $999.92M | 0.55% |
| PDBC | 1.61% | $4.40B | 0.59% |
| DUSB | 2.10% | $797.63M | 0.15% |
| DBC | 2.43% | $1.39B | 0.87% |
| JBBB | 2.45% | $1.26B | 0.49% |
| SGOV | 2.54% | $27.53B | 0.09% |
| SHV | 2.91% | $18.13B | 0.15% |
| USCI | 3.04% | $185.47M | 1.07% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -41.83% | $388.04M | 1.43% |
| USDU | -20.38% | $201.97M | 0.5% |
| VIXY | -20.19% | $195.31M | 0.85% |
| UUP | -17.68% | $309.25M | 0.77% |
| CTA | -15.61% | $350.27M | 0.78% |
| EQLS | -13.15% | $76.08M | 1% |
| KMLM | -10.11% | $353.87M | 0.9% |
| AGZD | -9.37% | $142.76M | 0.23% |
| TAIL | -8.44% | $67.98M | 0.59% |
| KCCA | -8.37% | $220.51M | 0.87% |
| WEAT | -7.52% | $120.27M | 0.28% |
| BOXX | -4.87% | $4.43B | 0.1949% |
| DBA | -4.75% | $755.88M | 0.93% |
| BILZ | -4.46% | $563.02M | 0.14% |
| TPMN | -4.27% | $40.60M | 0.65% |
| MINT | -4.24% | $11.62B | 0.35% |
| DBO | -3.26% | $217.57M | 0.77% |
| HDRO | -3.25% | $164.26M | 0.3% |
| PREF | -1.55% | $999.92M | 0.55% |
| FLRN | -1.35% | $2.33B | 0.15% |
News
Yahoo
MannKind ( NASDAQ:MNKD ) Third Quarter 2024 Results Key Financial Results Revenue: US$70.1m (up 37% from 3Q 2023). Net...
Yahoo
Q3 2024 MannKind Corp Earnings Call
Yahoo
MannKind Corp (MNKD) reports a 37% revenue increase, driven by Tyvaso DPI and Afrezza, while navigating market challenges and advancing its pipeline.
Yahoo
MNKD earnings call for the period ending September 30, 2024.
Yahoo
The headline numbers for MannKind (MNKD) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Yahoo
MannKind (MNKD) delivered earnings and revenue surprises of 0% and 9.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.